You just read:

Keryx Biopharmaceuticals to Hold Conference Call Tomorrow at 8:00 AM ET to Discuss Top-Line Results from Zerenex™ Phase 3 Long-Term Study

News provided by

Keryx Biopharmaceuticals, Inc.

Jan 27, 2013, 06:15 EST